Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Desmosomes01:05

Desmosomes

5.9K
The term desmosome derives from the Greek words "desmo" and "soma" meaning "adhesion bodies." This structure was first observed during the late 1800s and described as small, dense nodules in the epidermis. Desmosomes are button-like structures that help form an interlinked network of intermediate filaments across the cells. These junctions are  essential to hold cells together under mechanical stress and to maintain tissue integrity. Desmosomes are multi-protein...
5.9K
Surface Membrane Barriers01:18

Surface Membrane Barriers

1.7K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.7K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

643
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
643
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

1.0K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.0K
Types of Membrane Protrusions01:28

Types of Membrane Protrusions

3.1K
The protrusion of the cell surface is an initial step for several cellular processes, including cell migration, phagocytosis, and neurite outgrowth. These membrane protrusions are a result of cytoskeletal rearrangement. The most  widely observed cell protrusions include lamellipodia, pseudopodia, filopodia, microvilli, invadopodia, and podosomes. These protrusions can be of two types — static or dynamic.
The microvilli, an example of stable protrusions, are finger-like projections...
3.1K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

775
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
775

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International development of Investigator Global Assessment scores for pemphigus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Complement Activation May Drive the Pathogenicity of Anti-α6 and Anti-β4 Integrin Antibodies In Vivo.

Biomolecules·2026
Same author

Selective Complement Inhibition in Anti-p200 Pemphigoid: Immune Infiltrate Profiles and Therapeutic Implications Compared to Bullous Pemphigoid.

Biomolecules·2026
Same author

Comparative performance of four immunoassays for antilaminin 332 serum IgG in mucous membrane pemphigoid: a multicentre prospective blinded study.

The British journal of dermatology·2026
Same author

Inflammatory signatures in bullous pemphigoid-approaching precision medicine?

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Autoimmune Bullous Diseases: Therapeutic Update.

Drugs·2026
Same journal

Rethinking immunosuppression in limited cutaneous systemic sclerosis. The lcSSc conundrum; pros and cons for a timely immunosuppressive treatment.

Autoimmunity reviews·2026
Same journal

Kidney failure in patients with ANCA-associated vasculitis: A systematic review of outcomes.

Autoimmunity reviews·2026
Same journal

The role of antimicrobial peptides in rheumatoid arthritis: From mucosal predisposition to chronic synovitis.

Autoimmunity reviews·2026
Same journal

The role of short-chain fatty acids as key mediators of gut microbiota - host crosstalk in thyroid diseases.

Autoimmunity reviews·2026
Same journal

Intermittent hydrarthrosis (periodic synoviosis): A narrative review.

Autoimmunity reviews·2026
Same journal

Unraveling giant cell arteritis: From immunopathology to emerging targeted therapies (2026 update).

Autoimmunity reviews·2026
See all related articles

Related Experiment Video

Updated: Oct 7, 2025

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

435

Mucous membrane pemphigoid.

Gefei Du1, Sabrina Patzelt2, Nina van Beek3

  • 1Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany; Department of Oral Medicine, School and Hospital of Stomatology, Wuhan University, Wuhan, China.

Autoimmunity Reviews
|January 7, 2022
PubMed
Summary
This summary is machine-generated.

Mucous membrane pemphigoid (MMP) is a rare autoimmune blistering disease affecting mucous membranes. Diagnosis involves clinical signs and immunofluorescence, with potential links to malignancy in some cases.

Keywords:
AutoimmunityBP180Laminin 332MalignancyMucous membrane pemphigoidS3 guidelinesType VII collagen

More Related Videos

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.6K
Application of a Mouse Ligated Peyer’s Patch Intestinal Loop Assay to Evaluate Bacterial Uptake by M cells
05:59

Application of a Mouse Ligated Peyer’s Patch Intestinal Loop Assay to Evaluate Bacterial Uptake by M cells

Published on: December 17, 2011

19.8K

Related Experiment Videos

Last Updated: Oct 7, 2025

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

435
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.6K
Application of a Mouse Ligated Peyer’s Patch Intestinal Loop Assay to Evaluate Bacterial Uptake by M cells
05:59

Application of a Mouse Ligated Peyer’s Patch Intestinal Loop Assay to Evaluate Bacterial Uptake by M cells

Published on: December 17, 2011

19.8K

Area of Science:

  • Immunodermatology
  • Autoimmune Blistering Diseases
  • Mucosal Immunology

Background:

  • Mucous membrane pemphigoid (MMP) is a heterogeneous autoimmune disorder affecting epithelia, primarily oral and ocular mucosa.
  • Characterized by autoantibodies against basement membrane proteins like BP180 and laminin 332.
  • Lesions can lead to severe scarring, visual impairment, and functional deficits in breathing and eating.

Purpose of the Study:

  • To provide a comprehensive overview of Mucous Membrane Pemphigoid (MMP).
  • To detail clinical heterogeneity, immunopathology, diagnostic strategies, and treatment approaches.
  • To highlight the association between anti-laminin 332 MMP and malignancy.

Main Methods:

  • Review of clinical presentation and immunopathological findings in MMP.
  • Analysis of autoantibody targets including BP180, laminin 332, BP230, and collagen VII.
  • Discussion of diagnostic methods like direct immunofluorescence microscopy and recent S3 guidelines.

Main Results:

  • MMP incidence is approximately 2/million/year in Central Europe.
  • Common autoantibodies include IgG against BP180 (75%), laminin 332 (10-20%), and BP230 (10-30%).
  • Anti-laminin 332 MMP is associated with malignancy in about 25% of cases.

Conclusions:

  • MMP diagnosis relies on clinical presentation and immunofluorescence detection of tissue-bound antibodies.
  • Management strategies vary based on clinical involvement (oral, ocular).
  • Further research is needed for understanding complexity, associations, and developing evidence-based therapies.